Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system

被引:63
作者
Ehlert, Erich M. [1 ]
Eggers, Ruben [1 ]
Niclou, Simone P. [2 ]
Verhaagen, Joost [1 ]
机构
[1] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroregenerat, Amsterdam, Netherlands
[2] Ctr Rech Publ Sante, NorLux Neurooncol Lab, Luxembourg, Luxembourg
来源
BMC NEUROSCIENCE | 2010年 / 11卷
关键词
SHORT HAIRPIN RNAS; SPINAL-CORD-INJURY; MAMMALIAN-CELLS; GUIDANCE MOLECULES; NEURITE OUTGROWTH; NUCLEAR EXPORT; GENE DELIVERY; IN-VIVO; EXPRESSION; REGENERATION;
D O I
10.1186/1471-2202-11-20
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: After a spinal cord lesion, axon regeneration is inhibited by the presence of a diversity of inhibitory molecules in the lesion environment. At and around the lesion site myelin-associated inhibitors, chondroitin sulfate proteoglycans (CSPGs) and several axon guidance molecules, including all members of the secreted (class 3) Semaphorins, are expressed. Interfering with multiple inhibitory signals could potentially enhance the previously reported beneficial effects of blocking single molecules. RNA interference (RNAi) is a tool that can be used to simultaneously silence expression of multiple genes. In this study we aimed to employ adeno-associated virus (AAV) mediated expression of short hairpin RNAs (shRNAs) to target all Semaphorin class 3 signaling by knocking down its receptors, Neuropilin 1 (Npn-1) and Neuropilin 2 (Npn-2). Results: We have successfully generated shRNAs that knock down Npn-1 and Npn-2 in a neuronal cell line. We detected substantial knockdown of Npn-2 mRNA when AAV5 viral vector particles expressing Npn-2 specific shRNAs were injected in dorsal root ganglia (DRG) of the rat. Unexpectedly however, AAV1-mediated expression of Npn-2 shRNAs and a control shRNA in the red nucleus resulted in an adverse tissue response and neuronal degeneration. The observed toxicity was dose dependent and was not seen with control GFP expressing AAV vectors, implicating the shRNAs as the causative toxic agents. Conclusions: RNAi is a powerful tool to knock down Semaphorin receptor expression in neuronal cells in vitro and in vivo. However, when shRNAs are expressed at high levels in CNS neurons, they trigger an adverse tissue response leading to neuronal degradation.
引用
收藏
页数:11
相关论文
共 41 条
[1]   Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: Comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors [J].
Blits, Bas ;
Derks, Sanne ;
Twisk, Jaap ;
Ehlert, Erich ;
Prins, Jolanda ;
Verhaagen, Joost .
JOURNAL OF NEUROSCIENCE METHODS, 2010, 185 (02) :257-263
[2]  
Bolsover S, 2008, RESTOR NEUROL NEUROS, V26, P117
[3]   Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo [J].
Boudreau, Ryan L. ;
Martins, Ines ;
Davidson, Beverly L. .
MOLECULAR THERAPY, 2009, 17 (01) :169-175
[4]   Induction of an interferon response by RNAi vectors in mammalian cells [J].
Bridge, AJ ;
Pebernard, S ;
Ducraux, A ;
Nicoulaz, AL ;
Iggo, R .
NATURE GENETICS, 2003, 34 (03) :263-264
[5]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]   Injury-induced class 3 semaphorin expression in the rat spinal cord [J].
De Winter, F ;
Oudega, M ;
Lankhorst, AJ ;
Hamers, FP ;
Blits, B ;
Ruitenberg, MJ ;
Pasterkamp, RJ ;
Gispen, WH ;
Verhaagen, J .
EXPERIMENTAL NEUROLOGY, 2002, 175 (01) :61-75
[7]   Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites [J].
Diederichs, Sven ;
Jung, Stephanie ;
Rothenberg, S. Michael ;
Smolen, Gromoslaw A. ;
Mlody, Barbara G. ;
Habert, Daniel A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (27) :9284-9289
[8]  
Gavazzi I, 2000, J COMP NEUROL, V423, P492
[9]   Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic [J].
Giering, Jeffery C. ;
Grimm, Dirk ;
Storm, Theresa A. ;
Kay, Mark A. .
MOLECULAR THERAPY, 2008, 16 (09) :1630-1636
[10]  
Giger RJ, 2008, RESTOR NEUROL NEUROS, V26, P97